Menu

IBMS Strategy 2022

IBMS Strategy 2022
8 February 2022
The IBMS has published our Strategy 2022

The bold new IBMS Strategy informed by members and developed by Council sets out our vision, mission and values, the key themes we will be focussing on and our core aims over the next five-years.

It establishes the continuation of our three member-focussed pillars - Support, Progress, Promote - and how we aim to deliver on these going forward.


Build upon our experience and expertise

  • The IBMS will support more access to HCPC registration through better uptake of our entry routes. Provide greater clarity of the routes to entry and encourage more students through the most efficient route to HCPC registration. Champion the role of trainers and training officers in the laboratory.
  • The IBMS will progress our current members' knowledge, experience and their careers through better and more relevant training and qualifications, using our existing structures but allowing a more agile application. Create a more inclusive approach to support greater diversity, championing our members' values such as in sustainability and clear professional standards.
  • The IBMS will promote our highest qualifications, widen the disciplines that these are available in and increase the numbers of our members accessing them.


Build and develop our future

  • The IBMS will promote our profile post-pandemic, developing a policy and engagement capability at government level for each of the four nations.
  • The IBMS will progress the number and range of members that we attract, within the UK and globally.
  • The IBMS will support the understanding of the benefit the profession and Biomedical Science delivers to society.



IBMS Chief Executive David Wells commented:

In a time of enormous change, it is right that the IBMS responds with an ambitious, exciting strategy to keep Biomedical Science at the heart of healthcare.


The strategy document, which goes into more detail around the core aims above, can be downloaded in full below.

Back to news listing